Cynthia L. Flowers's most recent trade in Lisata Therapeutics Inc was a trade of 15,789 Common Stock done . Disclosure was reported to the exchange on Jan. 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lisata Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 15,789 | 64,990 (0%) | 0% | 0 | Common Stock | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 20,000 | 15,889 (0%) | 0% | - | Common Stock | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | 18 Sep 2024 | 15,889 | 0 (0%) | 0% | - | Common Stock | ||
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 10,000 | 35,889 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | L. Flowers Cynthia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 19,480 | 49,201 (0%) | 0% | 0 | Common Stock | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 25,889 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 20,000 | 29,721 (0%) | 0% | 0 | Common Stock | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
G1 Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 10,000 | 15,889 (0%) | 0% | 0 | Common Stock | |
Lisata Therapeutics Inc | Cynthia L. Flowers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,430 | 145,847 (1%) | 0% | 0 | Common Stock |